Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers

被引：0
|
作者：
Muddu, V. [1 ]
Shah, A. [2 ]
Raj, A. [3 ]
Bahl, A. [4 ]
Thirumalairaj, R. [5 ]
Ghosh, J. [6 ]
Ostwal, V. [2 ]
Rajappa, S. [7 ]
Vora, A. [8 ]
Lavingia, V. [9 ]
Sharma, A. [10 ]
Khan, A. [1 ]
Rohatgi, N. [4 ]
Mahajan, M. [11 ]
Chandrakanth, M. [6 ]
Ramaswamy, A. [12 ]
机构：
[1] AIG Hosp, Hyderabad, India
[2] Tata Mem Hosp, Tata Mem Ctr, Mumbai, Maharashtra, India
[3] Sarvodaya Hosp, Faridabad, India
[4] Fortis Canc Inst, Gurgaon, India
[5] Apollo Canc Ctr, Chennai, Tamil Nadu, India
[6] Tata Med Ctr, Kolkata, India
[7] Basavatarakam Indo Amer Canc Hosp, Hyderabad, India
[8] HOPE Oncol Care Clin, New Delhi, India
[9] HCG Canc Ctr, Ahmadabad, Gujarat, India
[10] All India Inst Med Sci, New Delhi, India
[11] Pacific Med Coll Hosp, Udaipur, Rajasthan, India
[12] Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-209
引用
下载
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [11] Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment
    Cosgrove, David P.
    Reese, Emily S.
    Fulcher, Nicole M.
    Bobiak, Sarah S.
    Lamy, Francois-Xavier
    Allignol, Arthur
    Boyd, Marley
    Mahmoudpour, Seyed H.
    CANCER MEDICINE, 2023, 12 (04): : 4195 - 4205
  • [12] Chemotherapy for biliary tract cancer: real-world experience in a single institute
    Maeda, Osamu
    Ebata, Tomoki
    Shimokata, Tomoya
    Matsuoka, Ayumu
    Inada-Inoue, Megumi
    Morita, Sachi
    Takano, Yuko
    Urakawa, Hiroshi
    Miyai, Yuki
    Sugishita, Mihoko
    Mitsuma, Ayako
    Ando, Masahiko
    Mizuno, Takashi
    Nagino, Masato
    Ando, Yuichi
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2020, 82 (04): : 725 - 733
  • [13] Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer
    Lagenfelt, Hanna
    Blomstrand, Hakon
    Elander, Nils O.
    CANCERS, 2021, 13 (14)
  • [14] Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data
    Patrick Reimann
    Ilektra-Antonia Mavroeidi
    Jonathan Burghofer
    Hossein Taghizadeh
    Gerald Webersinke
    Stefan Kasper
    Georg Schreil
    Darius Morariu
    Andreas Reichinger
    Hideo Andreas Baba
    Patrick Kirchweger
    Martin Schuler
    Angela Djanani
    Gerald W. Prager
    Holger Rumpold
    Magdalena Benda
    Eva-Maria Schneider
    Sylvia Mink
    Thomas Winder
    Bernhard Doleschal
    Cancer Immunology, Immunotherapy, 73 (12)
  • [15] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN UNRESECTABLE ADVANCED AND METASTATIC BILIARY TRACT CANCERS (BTC): A LITERATURE REVIEW
    Peirce, V
    Qin, L.
    Geldman, E.
    Dadzie, R.
    Prince, S.
    Johal, S.
    VALUE IN HEALTH, 2023, 26 (06) : S36 - S37
  • [16] Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
    Rimini, Margherita
    Masi, Gianluca
    Lonardi, Sara
    Pressiani, Tiziana
    Lavacchi, Daniele
    Nichetti, Federico
    Jessica, Lucchetti
    Giordano, Guido
    Scartozzi, Mario
    Tamburini, Emiliano
    Pastorino, Alessandro
    Rapposelli, Ilario Giovanni
    Daniele, Bruno
    Martinelli, Erika
    Garajova, Ingrid
    Aprile, Giuseppe
    Schirripa, Marta
    Formica, Vincenzo
    Salani, Francesca
    Winchler, Costanza
    Bergamo, Francesca
    Balsano, Rita
    Gusmaroli, Eleonora
    Lorenzo, Angotti
    Landriscina, Matteo
    Pretta, Andrea
    Toma, Ilaria
    Pirrone, Chiara
    Diana, Anna
    Leone, Francesco
    Brunetti, Oronzo
    Brandi, Giovanni
    Garattini, Silvio Ken
    Satolli, Maria Antonietta
    Rossari, Federico
    Fornaro, Lorenzo
    Niger, Monica
    Zanuso, Valentina
    De Rosa, Antonio
    Ratti, Francesca
    Aldrighetti, Luca
    De Braud, Filippo
    Foti, Silvia
    Rizzato, Mario Domenico
    Vivaldi, Caterina
    Stefano, Cascinu
    Rimassa, Lorenza
    Antonuzzo, Lorenzo
    Casadei-Gardini, Andrea
    TARGETED ONCOLOGY, 2024, 19 (3) : 359 - 370
  • [17] Second-line chemotherapy (2L) in elderly patients with advanced biliary tract cancer (ABC): A multicenter real-world study.
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Ricci, Angela Dalia
    Palloni, Andrea
    Messina, Carlo
    Spallanzani, Andrea
    Saccoccio, Gioconda
    Mollica, Veronica
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [18] Real-world treatment patterns, resource utilization and costs in biliary tract cancers in the USA
    Wang, Liya
    Singhal, Mukul
    Valderrama, Adriana
    Nepal, Bal
    Kamble, Shital
    Eluri, Madhulika
    Malhotra, Usha
    Siegel, Abby
    Grabner, Michael
    Swami, Shilpi
    Javle, Milind
    FUTURE ONCOLOGY, 2024,
  • [19] Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
    Wu, Chiao-En
    Chou, Wen-Chi
    Hsieh, Chia-Hsun
    Chang, John Wen-Cheng
    Lin, Cheng-Yu
    Yeh, Chun-Nan
    Chen, Jen-Shi
    BMC CANCER, 2020, 20 (01)
  • [20] Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
    Chiao-En Wu
    Wen-Chi Chou
    Chia-Hsun Hsieh
    John Wen-Cheng Chang
    Cheng-Yu Lin
    Chun-Nan Yeh
    Jen-Shi Chen
    BMC Cancer, 20
12345